Lindbrook Capital, LLC Biogen Inc. Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 592 shares of BIIB stock, worth $92,352. This represents 0.01% of its overall portfolio holdings.

Number of Shares

592

Previous 727 18.57%

Holding current value

$92,352

Previous $168,000 32.14%

% of portfolio

0.01%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$189.07 - $236.8 $25,524 - $31,968	-135 Reduced 18.57%	592 $114,000
Q2 2024 Jul 31, 2024	BUY	$190.52 - $236.72 $35,436 - $44,029	186 Added 34.38%	727 $168,000
Q4 2023 Jan 31, 2024	SELL	$222.59 - $267.94 $18,029 - $21,703	-81 Reduced 13.02%	541 $139,000
Q3 2023 Oct 25, 2023	SELL	$253.3 - $285.89 $23,050 - $26,015	-91 Reduced 12.76%	622 $159,000
Q2 2023 Jul 28, 2023	BUY	$275.25 - $318.06 $3,853 - $4,452	14 Added 2.0%	713 $203,000
Q1 2023 Apr 26, 2023	BUY	$256.56 - $292.34 $33,352 - $38,004	130 Added 22.85%	699 $194,000
Q4 2022 Jan 24, 2023	BUY	$252.44 - $306.72 $11,864 - $14,415	47 Added 9.0%	569 $0
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $14,991 - $20,671	77 Added 17.3%	522 $139,000
Q2 2022 Aug 01, 2022	SELL	$187.54 - $223.02 $44,822 - $53,301	-239 Reduced 34.94%	445 $91,000
Q1 2022 Apr 21, 2022	BUY	$193.77 - $244.14 $39,141 - $49,316	202 Added 41.91%	684 $144,000
Q4 2021 Jan 18, 2022	BUY	$223.92 - $287.77 $52,845 - $67,913	236 Added 95.93%	482 $116,000
Q3 2021 Nov 05, 2021	SELL	$282.99 - $369.05 $26,318 - $34,321	-93 Reduced 27.43%	246 $70,000
Q2 2021 Jul 27, 2021	BUY	$259.0 - $414.71 $28,749 - $46,032	111 Added 48.68%	339 $117,000
Q1 2021 Apr 28, 2021	BUY	$242.95 - $284.63 $7,288 - $8,538	30 Added 15.15%	228 $64,000
Q4 2020 Jan 27, 2021	SELL	$236.26 - $355.63 $2,835 - $4,267	-12 Reduced 5.71%	198 $48,000
Q3 2020 Nov 03, 2020	SELL	$264.77 - $305.71 $4,236 - $4,891	-16 Reduced 7.08%	210 $60,000
Q2 2020 Jul 27, 2020	SELL	$258.66 - $342.55 $9,829 - $13,016	-38 Reduced 14.39%	226 $60,000
Q1 2020 Apr 22, 2020	BUY	$268.85 - $341.04 $7,796 - $9,890	29 Added 12.34%	264 $84,000
Q4 2019 Jan 27, 2020	BUY	$220.06 - $304.07 $3,741 - $5,169	17 Added 7.8%	235 $70,000
Q3 2019 Oct 31, 2019	SELL	$217.44 - $243.88 $1,087 - $1,219	-5 Reduced 2.24%	218 $51,000
Q2 2019 Jul 24, 2019	SELL	$219.29 - $241.72 $217,974 - $240,269	-994 Reduced 81.68%	223 $52,000
Q1 2019 Apr 23, 2019	BUY	$216.71 - $338.96 $9,318 - $14,575	43 Added 3.66%	1,217 $287,000
Q4 2018 Feb 07, 2019	BUY	$278.5 - $352.75 $326,959 - $414,128	1,174 New	1,174 $353,000

Others Institutions Holding BIIB

# of Institutions

1,036

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Biogen Inc. Transaction History